iPhone | iPad
Android
Huawei
The nominations have been revealed
KT APPDOWNLOAD
Covid-19: Bahrain approves emergency use for new regn-cov2 medicine
Manama - The coronavirus treatment protocol in the kingdom would reduce symptoms complications.
Bahrain on Wednesday approved the emergency use for regn-cov2 medicine, Regeneron Pharmaceuticals Inc’s and Roche's newly authorised Covid-19 antibody combination, as part of its coronavirus treatment protocol to treat existing cases with mild and moderate symptoms, the state news agency (BNA) reported.
The report said updating the corona treatment protocol in the kingdom would reduce symptoms complications.
REGN-COV2 contains a combination of Casirivimab and Imdevimab, which are drugs called “monoclonal antibodies”, that are designed to block viral attachment and entry into human cells to neutralise the virus.
UAE, Kuwait approve new Covid treatment
REGN-COV2 also received emergency use approval from the US FDA to treat mild to moderate symptoms of Covid-19 in non-hospitalised adults and adolescents of 12 years of age and older, who weigh at least 40 kg, and for those who are at high risk for developing severe Covid symptoms or of hospitalisation.
More news from
These collaborative initiatives continue to underscore the company's unwavering commitment to enhancing global trade forward
The PCB also agreed that the centrally contracted players can play in two other T20 leagues aside from the Pakistan Super League
Economic growth across the Gulf will remain strong in 2024, Moody's forecasts
Internationally renowned company will soon set up shop in the Emirates and is expected to start functioning in 2024
The Babar Azam-led side will spend a lot of time in Hyderabad, having arrived here Dubai where it had a long nine hour layover
IBMC will also launch a global multi-assets exchange
Infosys Finacle and Red Hat organizes high-level roundtable discussion in Dubai